FDA neurosciences chief Billy Dunn to leave immediately, analysts raise concern

(Reuters) - The U.S. Food and Drug Administration neurosciences head Billy Dunn will retire from his role effective immediately, the health regulator ...

Related Keywords

Bengaluru ,Karnataka ,India ,Shinjini Ganguli ,Teresa Buracchio ,Sriparna Roy ,Maury Raycroft ,Caroline Humer ,Billy Dunn ,Eisai Co Alzheimer ,Drug Administration ,Biogen Inc ,Reuters ,Amylyx Pharmaceuticals Inc Relyvrio ,Office Of Neuroscience ,Amylyx Pharmaceuticals ,Reata Pharmaceuticals Inc ,Amylyx Pharmaceuticals Inc ,